Rehermann, Barbara
- National Institute of Diabetes and Digestive and Kidney Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,085
- Sustained Excellence
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$4M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#1,085
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Rehermann, Barbara as a PI. Multi-PI records show the full award amount for context.
- 1ZIADK054508-26ZIAContact PIRegulation of hepatic and systemic immune responses$2.6Maward amount
- 1ZIADK054509-26ZIAContact PIImmunology of Acute and Chronic Viral Hepatitis$1.2Maward amount
- 1ZIADK054516-17ZIAContact PIRole of the innate immune defenses in viral infections$242.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Rehermann, Barbara as a PI.
FY2023 award administered by National Institute of Diabetes and Digestive and Kidney Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Institute of Diabetes and Digestive and Kidney Diseases
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #5111
- 2008$2M Cumulative Funding
- 2008Entered Top 25% NationallyRanked #3609
- 2010$5M Cumulative Funding
- 2013$10M Cumulative Funding
- 2014Entered Top 10% NationallyRanked #1999
- 2018$25M Cumulative Funding